Transarterial embolization

PROCEDURE4 trials

Sponsors

Okayama University Hospital, Wake Forest University Health Sciences, Medical University of South Carolina, Zhejiang Raygene Pharmaceuticals Co., Ltd

Conditions

ChemoembolizatonHepatic CarcinomaHepato Cellular Carcinoma (HCC)Hepatocellular CarcinomaHepatomaLiver Cancer, AdultLiver Cell CarcinomaLiver Cell Carcinoma, Adult

Phase 1

Evaluate the Effect of Tirazamine on Primary Liver Cancer.

TerminatedNCT06848556

Zhejiang Raygene Pharmaceuticals Co., LtdHepato Cellular Carcinoma (HCC)

Start: 2021-05-14End: 2023-11-20Updated: 2025-02-27

Unknown Phase

Preoperative arterial embolization of hepatocellular carcinoma using DC beads; embolization and resect study

Active, not recruitingJPRN-UMIN000014607

Okayama University Hospitalhepatocellular carcinoma

Start: 2014-09-01Target: 6Updated: 2025-07-18

TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma

TerminatedNCT02704130

Wake Forest University Health SciencesHepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult +2

Start: 2016-03-31End: 2018-01-31Updated: 2022-04-22

Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).

CompletedNCT03163186

Medical University of South CarolinaChemoembolizaton, Hepatic Carcinoma, Transarterial Embolization

Start: 2015-12-01End: 2016-08-18Updated: 2017-05-22